home | write | русский
ABOUT COMPANY  QUESTIONS AND ANSWERS  CONTACTS
searchsearch
Main / About company / History
   
-

History

Pharmaceutical company Sotex was founded in 1999.

Sotex initially filled and packaged ready-made drugs under contracts with well-known western manufacturers: Nycomed, Lek, Pliva, Krka. This allowed the company to gain experience in production and quality control according to western standards.

2005

Production of injectable forms launched. The Sotex plant became one of the first Russian enterprises built in full compliance with EU GMP requirements.

2006

Sotex began licensed production of injectable drugs in partnership with foreign pharmaceutical manufacturers.

2008

Sotex launched a line for production of genetically engineered drugs in pre-filled syringes.

2009

Sotex started exports to neighboring and distant countries.

2011

Acquisition of 100% of the business and assets of OJSC AnviLab allowed for a rapid growth of the product portfolio in the OTC segment.

2014

A dedicated production area was launched to produce genetically-engineered substance erythropoietin – the API in Eralfon® ready formulation.

2015

A thirdampoule production line was launched, which allowed Sotex to double its injectable formulations production capacities.

2016

Sotex ampoule production received an EU GMP certificate.

2017

PROTEK Group finalized acquisition of Rafarma.







Copyright © 2006
«Sotex» Pharm Firm»
22/4, build. 7, Kashirskoye Schosse.
Moscow, Russia
Phone numbers: (495) 231-15-12
E-mail: info@sotex.ru
Developed by Individ
Powered by  Bitrix